Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Oka

Showing results (331-340 of 966) with videos related to

Pageof 97
Sort By:
Chemical & Pharmaceutical Bulletin|January 1, 1989
Synthesis and antiulcer activity of the metabolites of 2-(4-ethyl-1-piperazinyl)-4-phenylquinoline dimaleate (AS-2646), a novel gastric antisecretory and antiulcer agentK Hino, K Kawashima, M Oka, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1992
Role of lysophosphatidylcholine in T-lymphocyte activation: involvement of phospholipase A2 in signal transduction through protein kinase CY Asaoka, M Oka, K Yoshida, et al.
Biochemical Pharmacology|August 15, 1989
Myosin light-chain kinase inhibitor, 1-(5-chlornaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine (ML-9), inhibits catecholamine secretion from adrenal chromaffin cells by inhibiting Ca2+ uptake into the cellsA Nakanishi, M Yoshizumi, S Hamano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 5, 1997
[The study of continuous infusion chemotherapy with low-dose cisplatin and 5-fluorouracil for patients with primary liver cancer]T Takao, M Nishida, Y Maeda, et al.
Acta Orthopaedica Scandinavica|January 6, 2001
Acetabular augmentation using a glass-ceramic block: 3 patients followed 3-4 yearsS Yoshii, M Oka, T Yamamuro, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1992
Inhibition by amiloride of ouabain-evoked catecholamine secretion from cultured adrenal chromaffin cells: evidence for its blocking action on interaction between ouabain and Na+/K(+)-pumpK Morita, M Azuma, S Hamano, et al.
Spine|May 1, 1991
Analysis and prevention of spinal column deformity following cervical laminectomy. I. Pathogenetic analysis of postlaminectomy deformitiesT Saito, T Yamamuro, J Shikata, et al.
Biochemical Pharmacology|June 21, 1991
Inhibitory action of brovincamine on catecholamine secretion from cultured bovine adrenal medullary cells: possible relation to its blocking action on Ca2+ channelsK Morita, A Nakanishi, Y Murakumo, et al.
Applied Optics|November 2, 2010
Useful laser source criteria for optical storage employing extended eye-diagram jitter theoryS Kubota, M Oka, N Eguchi, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1988
Relation between bone erosions and rheumatoid factor IgA and IgM isotypes in recent onset rheumatoid arthritisT Möttönen, P Hannonen, I Jokinen, et al.
Pageof 97

Showing results (331-340 of 966) with videos related to

Sort By:
Pageof 97
Chemical & Pharmaceutical Bulletin|January 1, 1989
Synthesis and antiulcer activity of the metabolites of 2-(4-ethyl-1-piperazinyl)-4-phenylquinoline dimaleate (AS-2646), a novel gastric antisecretory and antiulcer agentK Hino, K Kawashima, M Oka, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1992
Role of lysophosphatidylcholine in T-lymphocyte activation: involvement of phospholipase A2 in signal transduction through protein kinase CY Asaoka, M Oka, K Yoshida, et al.
Biochemical Pharmacology|August 15, 1989
Myosin light-chain kinase inhibitor, 1-(5-chlornaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine (ML-9), inhibits catecholamine secretion from adrenal chromaffin cells by inhibiting Ca2+ uptake into the cellsA Nakanishi, M Yoshizumi, S Hamano, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 5, 1997
[The study of continuous infusion chemotherapy with low-dose cisplatin and 5-fluorouracil for patients with primary liver cancer]T Takao, M Nishida, Y Maeda, et al.
Acta Orthopaedica Scandinavica|January 6, 2001
Acetabular augmentation using a glass-ceramic block: 3 patients followed 3-4 yearsS Yoshii, M Oka, T Yamamuro, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1992
Inhibition by amiloride of ouabain-evoked catecholamine secretion from cultured adrenal chromaffin cells: evidence for its blocking action on interaction between ouabain and Na+/K(+)-pumpK Morita, M Azuma, S Hamano, et al.
Spine|May 1, 1991
Analysis and prevention of spinal column deformity following cervical laminectomy. I. Pathogenetic analysis of postlaminectomy deformitiesT Saito, T Yamamuro, J Shikata, et al.
Biochemical Pharmacology|June 21, 1991
Inhibitory action of brovincamine on catecholamine secretion from cultured bovine adrenal medullary cells: possible relation to its blocking action on Ca2+ channelsK Morita, A Nakanishi, Y Murakumo, et al.
Applied Optics|November 2, 2010
Useful laser source criteria for optical storage employing extended eye-diagram jitter theoryS Kubota, M Oka, N Eguchi, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1988
Relation between bone erosions and rheumatoid factor IgA and IgM isotypes in recent onset rheumatoid arthritisT Möttönen, P Hannonen, I Jokinen, et al.
Pageof 97